💼 Business 10h ago · Kinjel Shah

Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Quartz (QZ)

Global business news for the new economy

Source ↗ 👁 0 💬 0

Amneal Pharmaceuticals taps GLP-1 growth via a Pfizer-linked manufacturing deal, gaining exposure without clinical risks while scaling injectables and peptides.

Comments (0)

More Like This

I'm a 62-year-old paralegal who turned my needlepoint hobby into a side hustle. Gen Z are some of my best customers.

All Content from Business Insider · 58m ago

Pantry items you're probably keeping for too long, according to Reader’s Digest

Quartz · 1h ago

From supply-rich Austin to high-priced Miami, Zillow maps the great U.S. rent divide

Quartz · 1h ago

Americans may be stuck with $4 gas for a while

Quartz · 1h ago

I found out I didn't get a job from a Facebook post. I told the employer it was wrong not to tell me directly.

All Content from Business Insider · 1h ago

What bets are lawmakers and staffers making on prediction markets? They're not required to tell us.

All Content from Business Insider · 1h ago